These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8428607)

  • 1. Transgenic animal models of sickle cell disease.
    Fabry ME
    Experientia; 1993 Jan; 49(1):28-36. PubMed ID: 8428607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell membrane and density changes under ambient and hypoxic conditions in transgenic mice producing human sickle hemoglobin.
    Reilly MP; Chomo MJ; Obata K; Asakura T
    Exp Hematol; 1994 Jun; 22(6):501-9. PubMed ID: 8187846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A transgenic mouse model of sickle cell disorder.
    Greaves DR; Fraser P; Vidal MA; Hedges MJ; Ropers D; Luzzatto L; Grosveld F
    Nature; 1990 Jan; 343(6254):183-5. PubMed ID: 2296310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD.
    Trudel M; Saadane N; Garel MC; Bardakdjian-Michau J; Blouquit Y; Guerquin-Kern JL; Rouyer-Fessard P; Vidaud D; Pachnis A; Roméo PH
    EMBO J; 1991 Nov; 10(11):3157-65. PubMed ID: 1915288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockout-transgenic mouse model of sickle cell disease.
    Ryan TM; Ciavatta DJ; Townes TM
    Science; 1997 Oct; 278(5339):873-6. PubMed ID: 9346487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human sickle hemoglobin in transgenic mice.
    Ryan TM; Townes TM; Reilly MP; Asakura T; Palmiter RD; Brinster RL; Behringer RR
    Science; 1990 Feb; 247(4942):566-8. PubMed ID: 2154033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.
    Fabry ME; Costantini F; Pachnis A; Suzuka SM; Bank N; Aynedjian HS; Factor SM; Nagel RL
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12155-9. PubMed ID: 1465455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.
    Pászty C; Brion CM; Manci E; Witkowska HE; Stevens ME; Mohandas N; Rubin EM
    Science; 1997 Oct; 278(5339):876-8. PubMed ID: 9346488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oxygen inhalation on endogenous erythropoietin kinetics, erythropoiesis, and properties of blood cells in sickle-cell anemia.
    Embury SH; Garcia JF; Mohandas N; Pennathur-Das R; Clark MR
    N Engl J Med; 1984 Aug; 311(5):291-5. PubMed ID: 6738642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of a mouse model of sickle cell anemia.
    Ieremia J; Blau CA
    Blood Cells Mol Dis; 2002; 28(2):146-51. PubMed ID: 12064910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.
    Chang JC; Lu R; Lin C; Xu SM; Kan YW; Porcu S; Carlson E; Kitamura M; Yang S; Flebbe-Rehwaldt L; Gaensler KM
    Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14886-90. PubMed ID: 9843985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease.
    Fabry ME; Kennan RP; Paszty C; Costantini F; Rubin EM; Gore JC; Nagel RL
    J Clin Invest; 1996 Dec; 98(11):2450-5. PubMed ID: 8958206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.
    He Z; Russell JE
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10635-40. PubMed ID: 12124399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards a mouse model for sickle cell disease: HB SAD.
    Trudel M; Garel MC; Saadane N; Rouyer-Fessard P; Vidaud D; Costantini F; Beuzard Y
    Nouv Rev Fr Hematol (1978); 1990; 32(6):407-8. PubMed ID: 2101873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transgenic mouse model of hemoglobin S Antilles disease.
    Popp RA; Popp DM; Shinpock SG; Yang MY; Mural JG; Aguinaga MP; Kopsombut P; Roa PD; Turner EA; Rubin EM
    Blood; 1997 Jun; 89(11):4204-12. PubMed ID: 9166865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partially oxygenated sickled cells: sickle-shaped red cells found in circulating blood of patients with sickle cell disease.
    Asakura T; Mattiello JA; Obata K; Asakura K; Reilly MP; Tomassini N; Schwartz E; Ohene-Frempong K
    Proc Natl Acad Sci U S A; 1994 Dec; 91(26):12589-93. PubMed ID: 7809083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of irreversibly sickled cells in reducing the osmotic fragility of red cells in sickle cell anemia.
    Figueiredo MS; Zago MA
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):49-56. PubMed ID: 2932889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of glutathione levels and Heinz body formation to irreversibly sickled cells in sickle cell anemia.
    Wetterstroem N; Brewer GJ; Warth JA; Mitchinson A; Near K
    J Lab Clin Med; 1984 Apr; 103(4):589-96. PubMed ID: 6699474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niprisan (Nix-0699) improves the survival rates of transgenic sickle cell mice under acute severe hypoxic conditions.
    Iyamu EW; Turner EA; Asakura T
    Br J Haematol; 2003 Sep; 122(6):1001-8. PubMed ID: 12956772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.